首页 | 本学科首页   官方微博 | 高级检索  
     

口服降糖药应用情况分析
引用本文:刘策时,孙春华,穆林,谭玲,刘蕾. 口服降糖药应用情况分析[J]. 中国医院用药评价与分析, 2010, 0(9): 800-802
作者姓名:刘策时  孙春华  穆林  谭玲  刘蕾
作者单位:[1]北京大学医学部药学院药事管理与临床药学系,北京100083 [2]卫生部北京医院药学部,北京100730
摘    要:目的:评估卫生部北京医院口服降糖药的应用情况,为临床合理用药提供参考。方法:对我院2006--2009年口服降糖药的用药频度(DDDs)、销售金额、日用药金额(DDC)等数据进行统计、分析。结果:4年来我院口服降糖药销售金额持续增长。销售金额排序居第1位的始终是阿卡波糖,DDDs排序居前2位的始终是阿卡波糖和二甲双胍,销售金额序号与DDDs序号比值在0.4~2.75之间。结论:我院口服降糖药使用基本合理,其首选药是阿卡波糖。

关 键 词:口服降糖药  用药分析  用药频度  日用药金额

Utilization of Oral Hypoglycemic Drugs in Our Hospital from 2006 to 2009
LIU Ce-shi,SUN Chun-hua,MU Lin,TAN Ling,LIU Lei. Utilization of Oral Hypoglycemic Drugs in Our Hospital from 2006 to 2009[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2010, 0(9): 800-802
Authors:LIU Ce-shi  SUN Chun-hua  MU Lin  TAN Ling  LIU Lei
Affiliation:1. Dept. of Pharmacy Administration and Clinical Pharmacy, Peking University, Beijing 100083, China; 2. Dept. of Pharmacy, Beijing Hospital, Ministry of Health, Beijing 100730, China)
Abstract:OBJECTIVE: To analyze the use of oral hypoglycemic drugs in our hospital for reference of clinical rational drug use. METHODS: The utilization of oral hypoglyeemic drugs in our hospital from 2006 to 2009 was analyzed statistically in respect of its DDDs, consumption sum and daily drug cost ( DDC ) etc. RESULTS: The consumption sum of oral hypoglycemic drugs increased year by year from 2006 to 2009, with Acarbose dominating the first place stably on the consumption list. The top two oral hypoglycemic drugs on DDDs list were Acarbose and Metformin. The ratios of consumption sum to DDDs ranged from 0.4 to 2.75. CONCLUSION: The use of oral hypoglycemic drugs in our hospital was rational basically, with Acarbose being the first choice.
Keywords:Oral hypoglycemic drugs  Drug-use analyze  DDDs  DDC
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号